Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
This is the easy part
In a STEP 8 trial, adults with overweight or obesity (without diabetes) experienced greater weight loss with once-weekly semaglutide compared to once-daily liraglutide, alongside diet and exercise counseling
Some people experience significant appetite changes before seeing meaningful changes on the scale
These findings reinforce the view that obesity is a chronic, relapsing condition, and that ongoing treatment may be necessary to sustain the health benefits achieved with incretin-based therapies
Consent for publication All authors have agreed to publish this article
The clinic also references quality testing in FDA- and DEA-registered labs, but does not disclose which labs, which pharmacy partners it uses, or who its partnering medical practitioners are
